main content start

Curtas de vídeo

Mais popular

Mais popular

Popular in Sem nome
  • 3m 56s

    Duration of trastuzumab in patients with Her2 positive Metastatic Breast Cancer in prolonged remission

    There are no randomized clinical trials addressing the continued use of Trastuzumab for Her2 positive MBC patients in prolonged remission and has become important and relevant clinical question.
    her2 positive mbc prolonged remission trastuzumab duration
  • 3m 36s

    Tumor Infiltrating Lymphocytes as Predictive Biomarker in Breast Cancer

    Immune cells known as tumor-infiltrating lymphocytes (TILs) are thought to be a promising, affordable biomarker with prognostic and predictive potential.
    tumor-infiltrating lymphocytes (tils) promising biomarker
  • 3m 36s

    Tumor Infiltrating Lymphocytes as Predictive Biomarker in Breast Cancer

    Immune cells known as tumor-infiltrating lymphocytes (TILs) are thought to be a promising, affordable biomarker with prognostic and predictive potential.
    tumor-infiltrating lymphocytes (tils) promising biomarker
  • Myelodysplastic Syndromes2m 25s

    Factors that influence treatment adherence and outcomes in MDS

    Anticipate & manage adverse events to optimize treatment outcomes: Patients treated with hypomethylating agents are at increased risk of cytopenias & might need support with transfusions.
    adverse events hypomethylating agents mds treatment compliance
  • Myelodysplastic Syndromes2m 31s

    Duration of treatment does it improve outcomes Hypomethylating agents in MD

    Need to maximise the response to hypomethylating agents: Standard of care for high-risk Myelodysplastic Syndromes is Hypomethylating agents. Average time to response is about 3 months with either Azacytidine or Decitabine.
    duration of treatment hypomethylating agents mds
  • Câncer de próstata2m 21s

    Role of Geriatric Assessment in prostate Cancer

    Average at diagnosis of prostate cancer is ~65 years & patients usually have multiple co- morbidities and may be on treatment with multiple prescribed medications.
    geriatric assessment prostate cancer
  • Mieloma múltiplo2m 43s

    Practice Points: Management of Infections in Multiple Myeloma

    Patients with Multiple Myeloma and plasma cell disorders are at high risk of infections because of compromised immune system. Associated co morbidities can also increase susceptibility to certain infections.
    vaccination myeloma prophylaxis infections
  • Oncospecials2m 41s

    Low Dose Dasatinib Ready For Clinical Practice

    Several studies carried out by institutions of repute have shown that Dasatinib 50 mg is as effective as 100 mg with less side effects.
    low dose dasatinib dasatinib 50mg
  • Oncology3m 36s

    Tissue Agnostic Treatment options in Solid Tumors

    Tissue-agnostic treatment based on shared genetic aberrations have provided a new direction in cancer treatment. Emerging clinical evidence indicates that many molecular aberrations can be common across tumor types with different site of origin.
    personalized medicine precision medicine tissue agnostic treatment
  • Myelodysplastic Syndromes4m 34s

    Practical Approach for Using Iron Chelation Therapy in MDS

    Iron chelation therapy (ICT) in MDS is used to manage iron overload from frequent blood transfusions. It involves identifying patients who would benefit most, monitoring iron levels, and managing side effects of chelators
    iron chelation therapy (ict) iron overload risk reduction improved qol
  • Últimos vídeos

    Últimos vídeos

    Short Cards Listing

    Todos os vídeos

    Todos os vídeos

    Hola, ¿puedo ayudar?
    Suporte por bate-papoX
    Equipe de suporte
    Hola, ¿cómo puedo ayudarlo hoy?
    Seleccione una de las siguientes opciones.

    Buscar información

    No puedo iniciar sesión o registrarse

    compartilhar comentarios